Navigation Links
Acclaimed Author Lionel Shriver Supports Mesothelioma Awareness Day
Date:8/25/2014

Alexandria, VA (PRWEB) August 25, 2014

The Mesothelioma Applied Research Foundation (Meso Foundation) released today a video of award-winning author, Lionel Shriver, in which Ms. Shriver urges viewers to observe September 26th as Mesothelioma Awareness Day. The video can be watched on the Meso Foundation’s YouTube channel.

“Several years ago, one of my closest friends, was diagnosed with mesothelioma,” says Ms. Shriver in the video. “Her experience of living with the disease, and ultimately dying from it, moved me to write my tenth novel, ‘So Much for That.’”

“So Much for That” is a novel that tackles the complicated topic of healthcare in the United States, through the experience of a mesothelioma patient and her family.

In the video, viewers are urged to visit the organization’s website, curemeso.org, to learn more about Mesothelioma Awareness Day.

Ms. Shriver is best known as the author of the award-winning novel “We Need to Talk About Kevin,” and “Big Brother.”

Mesothelioma Awareness Day is a grassroots movement established in 2004 by volunteers of the Meso Foundation with the goal of bringing more attention and funding to this historically-neglected cancer.

“On behalf of the mesothelioma community, I am infinitely grateful to Ms. Shriver for her help in raising awareness,” said nurse practitioner and executive director of the Mesothelioma Applied Research Foundation, Mary Hesdorffer.

“More awareness of this disease and the consequent increased funding for research, education, support, and advocacy is exactly what is needed to help us save lives,” added Ms. Hesdorffer.

Mesothelioma is a malignant tumor of the lining of the lung, abdomen, or heart known to be caused by exposure to asbestos. With the life expectancy of less than one year after diagnosis, medical experts consider it one of the most aggressive and deadly of all cancers. An estimated one-third of those who develop mesothelioma were exposed while serving in the Navy or working in shipyards. Currently, few treatment options exist. There is no cure.

ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively seeks philanthropic support to fund mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer-reviewed scientific research to develop life-saving treatments for this extremely aggressive cancer. To date, the Foundation has awarded over $8.7 million to research. More information is available at http://www.curemeso.org.

###

Read the full story at http://www.prweb.com/releases/2014/08/prweb12118242.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. CVS Caremark Adds New, Natural Acclaimed Hair Care Line to its Beauty Roster
2. Oregon's Most Acclaimed Medical Marijuana "Canna Kitchen" Whips Up Smokeless Remedies for Albany OMMP Patients
3. Acclaimed 9/11 Photographer Gary Suson to Conduct 'Final' Press Interviews
4. Edward J. Bergman, New Jersey's Highly Acclaimed Mediator, Joins Leading Website Mediation.com
5. Patient Advocate for CancerConnect.com and Acclaimed Writer, Jamie Reno, Delivers Devastating News of Lifesaving Cancer Drug's Discontinuation
6. Acclaimed Fitness Business Consultant Shows Personal Trainers How to Grow a Fitness Business with Search Engine Optimization
7. Nationally Acclaimed Addictions Specialist Dan Cronin Joins Journey Malibu - The Leader in One-on-One Treatment
8. Kick-Start Your Weight Loss Today and Get a Massive 15-Percent Off the Acclaimed Pure Garcinia Cambogia Extract; Only While Stocks Last
9. Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website
10. Living Well Medical, a Top NYC Medical Facility, Welcomes Acclaimed Orthopedist Dr. Randall Victor Ehrlich, M.D.
11. Acclaimed Texas Surgeon Offers Hope through Expertise in Erb’s Palsy Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... country’s leading private owners, developers and operators of commercial real estate proudly announced ... its 2015 Heart Health initiative. Team members portfolio-wide will continue Olshan Properties’ ...
(Date:5/4/2016)... MD (PRWEB) , ... May 04, 2016 , ... ... Ostomy and Continence Nurses (WOCN) Society™ and Canadian Association for Enterostomal Therapy ... event promotion, time saving and planning tools to attendees and exhibitors for the ...
(Date:5/4/2016)... Gilmer, TX (PRWEB) , ... May 04, 2016 ... ... commencement of a master charity program created to assist the people of their ... working closely with nonprofit organizations and community leaders. Their hope is to bring ...
(Date:5/4/2016)... , ... May 04, 2016 , ... ... 2016. SS&A teamed up with one of the top website design companies to ... contains informative legal articles related to the law firm's main practice areas. These ...
(Date:5/4/2016)... ... 2016 , ... Nordic Naturals announces another breakthrough innovation—Omega Curcumin, ... synergistic combination of omega-3 fatty acids and potent antioxidants contains 1000 mg concentrated ... and 200 mg of N-Acetylcysteine (NAC). , Each nutrient plays a distinct ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... 2016 According to market research ... Growth and Demand Forecast to 2022 - Industry Insights ... Field, Very High Field, Low to Mid Field, and ... Spine, Musculoskeletal, Vascular, Breast, Pelvic and Abdomen, Cardiac, and ... (MRI) market was valued at $5,351.7 million in 2015, ...
(Date:5/3/2016)... Norgine B.V. und ... entscheidenden Meilenstein durch diese Veröffentlichung zur  Hepatischen ... um Patientenresultate  bei Verdauungs- und Lebererkrankungen zu ... Verständnis der Hepatischen Enzephalopathie bei und hebt ... Enzephalopathie in der Öffentlichkeit zu schaffen und ...
(Date:5/2/2016)... 2016  Celsion Corporation (NASDAQ: CLSN ), ... from the first cohort of patients in its ... Study) combining GEN-1, the Company,s DNA-based immunotherapy, with ... newly-diagnosed patients with advanced ovarian cancer who will ... In the first three patients dosed, GEN-1 plus ...
Breaking Medicine Technology: